TGFbeta1 polymorphisms and late clinical radiosensitivity in patients treated for gynecologic tumors.

[1]  H. Thierens,et al.  Microsatellite Polymorphisms in DNA Repair Genes XRCC1, XRCC3 and XRCC5 in Patients with Gynecological Tumors: Association with Late Clinical Radiosensitivity and Cancer Incidence , 2005, Radiation research.

[2]  H. Thierens,et al.  Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3, and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. , 2005, International journal of radiation oncology, biology, physics.

[3]  M. Dewhirst,et al.  Recent progress in defining mechanisms and potential targets for prevention of normal tissue injury after radiation therapy. , 2005, International journal of radiation oncology, biology, physics.

[4]  J. Yarnold,et al.  TGFB1 polymorphisms are associated with risk of late normal tissue complications in the breast after radiotherapy for early breast cancer. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  E. Carosella,et al.  Genetic and epigenetic features in radiation sensitivity , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[6]  E. Carosella,et al.  Genetic and epigenetic features in radiation sensitivity , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[8]  S. Wallace,et al.  Marked phenotypic variability in progressive diaphyseal dysplasia (Camurati–Engelmann disease): Report of a four‐generation pedigree, identification of a mutation in TGFB1, and review , 2004, American journal of medical genetics. Part A.

[9]  D. Riediger,et al.  Analysis of polymorphic TGFB1 codons 10, 25, and 263 in a German patient group with non-syndromic cleft lip, alveolus, and palate compared with healthy adults , 2004, BMC Medical Genetics.

[10]  H. Groen,et al.  Transforming growth factor-beta plasma dynamics and post-irradiation lung injury in lung cancer patients. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[11]  J. Overgaard,et al.  Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  C Norman Coleman,et al.  Effects of radiation on normal tissue: consequences and mechanisms. , 2003, The Lancet. Oncology.

[13]  H. Shin,et al.  Identification of novel variants in transforming growth factor‐beta 1 (TGFB1) gene and association analysis with bone mineral density , 2003, Human mutation.

[14]  J. Chang-Claude,et al.  A Transforming Growth Factorβ1 Signal Peptide Variant Increases Secretion in Vitro and Is Associated with Increased Incidence of Invasive Breast Cancer , 2003 .

[15]  A. Hajeer,et al.  Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients , 2003, International journal of radiation biology.

[16]  T. Samulski,et al.  Soluble TGFbeta type II receptor gene therapy ameliorates acute radiation-induced pulmonary injury in rats. , 2002, International journal of radiation oncology, biology, physics.

[17]  M. Dewhirst,et al.  Overexpression of extracellular superoxide dismutase protects mice from radiation-induced lung injury. , 2002, International journal of radiation oncology, biology, physics.

[18]  E. Vlková,et al.  Polymorphism R25P in the gene encoding transforming growth factor-beta (TGF-beta1) is a newly identified risk factor for proliferative diabetic retinopathy. , 2002, American journal of medical genetics.

[19]  James B. Mitchell,et al.  Mice lacking Smad3 are protected against cutaneous injury induced by ionizing radiation. , 2002, The American journal of pathology.

[20]  K. Flanders,et al.  Is Smad3 a major player in signal transduction pathways leading to fibrogenesis? , 2001, Chest.

[21]  M. Yokota,et al.  Association of a T29-->C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese. , 2000, Circulation.

[22]  M. Martin,et al.  TGF-beta1 and radiation fibrosis: a master switch and a specific therapeutic target? , 2000, International journal of radiation oncology, biology, physics.

[23]  C. S. Campbell,et al.  Transforming growth factor-beta (TGF-beta1) genotype and lung allograft fibrosis. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  S. Kumar,et al.  TGF‐β1 levels in pre‐treatment plasma identify breast cancer patients at risk of developing post‐radiotherapy fibrosis , 1999, International journal of cancer.

[25]  J. Gunn,et al.  Transforming growth factor-beta1 gene polymorphisms and coronary artery disease. , 1998, Clinical science.

[26]  L. Fink,et al.  Differential effect of radiation on endothelial cell function in rectal cancer and normal rectum. , 1998, American journal of surgery.

[27]  P. Hasleton,et al.  Genotypic variation in the transforming growth factor-beta1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. , 1998, Transplantation.

[28]  K. Ikeda,et al.  Association of a Polymorphism of the Transforming Growth Factor‐β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  M. Hauer-Jensen,et al.  Increased transforming growth factor beta (TGF-beta) immunoreactivity is independently associated with chronic injury in both consequential and primary radiation enteropathy. , 1997, International journal of radiation oncology, biology, physics.

[30]  M. Anscher,et al.  Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. , 1997, International journal of radiation oncology, biology, physics.

[31]  D. Arveiler,et al.  Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. , 1996, Hypertension.

[32]  D. Danielpour.  Induction of transforming growth factor‐β autocrine activity by all‐trans‐retinoic acid and 1α,25‐dihydroxyvitamin D3 in NRP‐152 rat prostatic epithelial cells , 1996 .

[33]  D. Grainger,et al.  Tamoxifen elevates transforming growth factor–β and suppresses diet–induced formation of lipid lesions in mouse aorta , 1995, Nature Medicine.

[34]  M. Anscher,et al.  Elevated Plasma Transforming Growth Factor-β1 Levels in Breast Cancer Patients Decrease After Surgical Removal of the Tumor , 1995, Annals of surgery.

[35]  R J Myerson,et al.  Late effects of radiation therapy on the gastrointestinal tract. , 1995, International journal of radiation oncology, biology, physics.

[36]  H. Stunnenberg.  Mechanisms of transactivation by retinoic acid receptors , 1993, BioEssays : news and reviews in molecular, cellular and developmental biology.

[37]  M. Martin,et al.  Temporal modulation of TGF-beta 1 and beta-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. , 1993, Radiation research.

[38]  M. Anscher,et al.  Transforming growth factor-beta 1 expression in irradiated liver. , 1990, Radiation research.

[39]  M. Sporn,et al.  Characterization of the promoter region of the human transforming growth factor-beta 1 gene. , 1989, The Journal of biological chemistry.

[40]  E. Chen,et al.  Intron-exon structure of the human transforming growth factor-β precursor gene , 1987 .

[41]  S. Warren.  Effects of radiation on normal tissues , 1980 .

[42]  P. Hozák,et al.  Post-treatment plasma transforming growth factor beta 1 (TGF-beta1) level predicts for late morbidity in patients with advanced head and neck cancer. , 2005, Neoplasma.

[43]  H. Hackstein,et al.  Prospective analysis of single nucleotide polymorphisms of the transforming growth factor beta-1 gene in Peyronie's disease. , 2003, The Journal of urology.

[44]  T. Spector,et al.  Genetic control of the circulating concentration of transforming growth factor type beta1. , 1999, Human molecular genetics.

[45]  Niels Gregersen,et al.  A Sequence variation , 1997 .

[46]  M. Sporn,et al.  Transforming Growth Factor-β1 Circulates in Normal Human Plasma and is Unchanged in Advanced Metastatic Breast Cancer , 1995 .

[47]  M. Anscher,et al.  Changes in plasma TGFβ levels during pulmonary radiotherapy as a predictor of the risk of developing radiation pneumonitis , 1993 .